New research added to concerns about the downsides of shedding pounds with popular weight-loss shots.
Novo Weight-Loss Drug Saxenda Poses Risk to Bone Health, Study FindsCarnival Boosts Outlook as Cruise Demand Keeps Breaking RecordsBybit Is Now the World’s Second-Largest Crypto ExchangeBrazil Central Bank in No Rush to Cut Again Amid Fiscal WoesBarclays CEO Says Bank Can’t Go ‘Cold Turkey’ on Oil ClientsSpain Adds Olive Oil to VAT Exemption Running Until September 30Kenya Lawmakers Agree to Drop Planned 2.
6% after April reboundCollege clampdown on track to halve student arrivals to CanadaThe Daily Chase: Collision conference underway, and a major deal in Canadian techCanada's economy 'set to turn a corner': TD EconomicsPaul Singer Is Pitching Wall Street's Own Brand of MAGARussia’s Oil Exports Drop the Most in Three Months on Port WorksAOC Is Getting Too Mainstream for Her Progressive BaseFrench Bonds Hint Investor Nerves Are Calming Ahead of ElectionEight Protesters Shot Dead...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Innovent’s Obesity Drug Shows Similar Weight Loss as Eli Lilly’sA new obesity drug co-developed by China’s Innovent Biologics Inc. and Eli Lilly & Co. has demonstrated significant weight loss in a late stage trial, paying the way for its approval in the country to compete with the blockbuster from Novo Nordisk A/S.
Read more »
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea StocksThe new class of weight-loss drugs are being tested as cure-alls for everything from knee replacements to liver disease and throwing corners of the stock market into disarray.
Read more »
Michigan’s Largest Insurer to Drop Weight-Loss Drug CoverageWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run by Michigan’s largest health insurer as companies grapple with whether the drugs are worth the cost.
Read more »
Can GLP-1 weight-loss drug manufacturers keep momentum up?As GLP-1 weight-loss drugs have boosted several healthcare stocks, Jennison Associates Head of Global Equity Mark Baribeau joins Market Domination Overtime...
Read more »
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to PatientsEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy.
Read more »
Structure Reports Early Oral Weight-Loss Drug Data Adding AllureStructure Therapeutics Inc. reported early-stage data on its oral weight-loss drug as the company looks to find a niche in the rapidly growing market.
Read more »